Running title: M. tuberculosis clinical isolate recognition by macrophages
Phenotypically distinct clinical isolates of
Mycobacterium tuberculosis (M.tb) are capable of altering the balance that exists between the pathogen and human host, and ultimately the outcome of infection. This study has identified two M.tb strains (i.e. HN885 and HN1554) among a bank of clinical isolates with a striking defect in phagocytosis by primary human macrophages when compared to strain Erdman, a commonly used laboratory strain for studies of pathogenesis. Mass spectrometry in conjunction with NMR studies unequivocally confirmed that both HN885 and HN1554 contain truncated and more branched forms of mannose-capped lipoarabinomannan (ManLAM) with a marked reduction of their linear arabinan (corresponding mainly to the inner Araf-α[1→5]-Araf unit) and mannan (with less 6-Manp residues and more substitutions in the linear Manp-α[1→6]-Manp unit) domains. The truncation in the ManLAM molecules produced by strains HN885 and HN1554 led to a significant reduction in their surface availability. In addition, there was a marked reduction of higher-order phosphatidyl-myo-inositol mannosides (PIMs) and the presence of dimycocerosates, triglycerides and phenolic glycolipid in their cell envelope. Less exposed ManLAM and reduced higher-order PIMs in strains HN885 and HN1554 resulted in their low association with the macrophage mannose receptor. Despite reduced phagocytosis, ingested bacilli replicated at a fast rate following serum opsonization. Our results provide evidence that the clinical spectrum of tuberculosis may be dictated not only by the host, but also by the amounts and ratios of surface exposed mycobacterial adherence factors defined by strain genotype.
Tuberculosis causes immense morbidity and mortality worldwide (1) . The causative bacterium, Mycobacterium tuberculosis (M.tb) is phagocytosed by and grows within host macrophages. Our recent studies (2;3) have led to the conclusion that M.tb is adapting to the human host by cloaking its cell envelope molecules with terminal mannosylated (i.e. Man-α[1→2]-Man) oligosaccharides that resemble the glycoforms of mammalian mannoproteins (4) . These molecules include the abundant mannose-capped lipoarabinomannan (ManLAM), lipomannan (LM), and phosphatidyl-myo-inositol mannosides (PIMs), which play a central role in M.tb immunopathogenesis (5) . ManLAM and higherorder PIMs (i.e. PIM 5 and PIM 6 ) have exposed Man-α[1→2]-Man non-reducing termini that engage the mannose receptor (MR) on human macrophages during phagocytosis (3;6;7) and dictate the intracellular fate of M.tb by regulating formation of the unique vesicular compartment in which M.tb survives within the human host (2;3).
To date, studies of M.tb phagocytosis have focused largely on use of the common laboratory virulent strains Erdman and H 37 R v , and the attenuated strain H 37 R a . Recently, banks of clinical isolates have been characterized in an attempt to link epidemiology and genetic analyses in order to better understand the pathogenesis of the tuberculosis (8) (9) (10) (11) . These population studies classified M.tb into three distinct genetic groups designated principal genetic group 1, 2, and 3 (PGG-1, -2, and -3) based on allelic variation in genes encoding gyrase and catalase-peroxidase (8) , two genes involved in antibiotic resistance (12;13) , and the pattern of the insertion sequence IS6110 (8) .
Studies using this bank of clinical isolates showed that different M.tb clinical isolates within the PPGs vary in their ability to cause disease in humans and are capable of inducing different immunologic responses in the host. In particular, M.tb HN878 is associated with an unusually high proportion of active cases of disease and a high frequency of extrapulmonary disease (10) . This has been attributed to immune subversion (14) . In contrast, the M.tb clinical isolate CDC1551 caused a low number of cases of active disease followed by an unusually high rate of seroconversion and it has been found to induce a more rigorous immunologic response (9;11).
Here we randomly selected M.tb strains from the bank of PGG-1, -2 and -3 M.tb isolates described above to screen for alterations in bacterial association with primary human macrophages in order to better characterize microbial determinants important in this process. We discovered that two phylogenetically related PGG-1 strains are significantly reduced in macrophage association and phagocytosis; and demonstrate increased intracellular growth following serum opsonization. These strains contain a truncated form of ManLAM buried within their cell envelope and a reduction in higher-order PIMs; thus they do not engage the MR during phagocytosis. They also contain phenolic glycolipid (PGL), triglycerides and dimycocerosates, all known virulence factors (14) (15) (16) . We propose a model for how distinct M.tb strains differ fundamentally in their macrophage interaction; a factor that may contribute to the increased representation of specific M.tb clones globally that impact the spectrum of human infections and disease.
Experimental Procedures
Chemical reagents and antibodies -All chemicals reagents were of the highest grade from SigmaAldrich (St. Louis, MO) unless otherwise specified. CS-35 and CS-40 murine mAbs were kindly provided by both the Tuberculosis Research Materials and Vaccine Testing contract (NO1-AI-75320) and Leprosy Research Support contract (NO1-AI-25469).
Growth conditions of M.tb strains -Randomly selected M.tb clinical isolates [HN731, HN804, HN885, HN1390, HN1538, and HN1554 from PGG-1; HN657, HN703 and HN810 from PGG-2; and HN362 from PGG-3] were recovered from patients in Houston, TX, and characterized as described (8;17) . M.tb Erdman (ATCC 35801, within PGG-2) and H 37 R v (ATCC 27294, within PGG-3) laboratory strains were also studied. Working stocks of all M.tb strains were grown on 7H11 plates and used as single suspensions as described (18) . Single cell suspensions were confirmed by high power light microscopy, repeating CFU assays several times to correlate the numbers of bacteria counted in the PetroffHausser chamber with CFUs, and performing tissue culture assays to ensure that the different clinical isolates settled comparably (similar buoyancies).
Isolation and preparation of human macrophages -Monocyte-derived macrophages (MDM) monolayers were prepared from healthy tuberculin negative human volunteers as described (19) . Monolayers (2 x 10 5 MDMs) for microscopy and CFUs were obtained by adherence to acid-washed glass coverslips or directly to plastic, respectively, in 24-well tissue culture plates for 2 h at 37°C.
Assay of M.tb association with MDMs -M.tb
association assays with human MDM monolayers was performed as previously described (19) . Briefly, MDM monolayers on coverslips in RPMI (Difco,/BD, Franklin Lakes, NJ) containing 20 mM Hepes (RH) and 2.5% autologous human serum or RPMI containing 20 mM Hepes and 1 mg/ml human serum albumin (RHH) were incubated with M.tb single suspensions (2 x 10 6 bacilli) for 2 h at 37°C in 5% CO 2 . MDM monolayers were washed to remove nonassociated bacilli, fixed in 10% formalin, washed again and then associated M.tb bacilli were stained with auramine-rhodamine. Mean ± SEM of cellassociated bacilli per MDM on triplicate coverslips was determined by counting ≥ 300 consecutive MDM per coverslip using phasecontrast and fluorescence microscopy (19) .
In some cases, MDMs were pre-incubated with anti-MR antibody (AbD Serotec, Raleigh, NC) at 10µg/ml for 20 min at 37°C to block the activity of the MR as previously described (2;3). For association with complement receptor 3 (CR3), CHO CR3 cells (1x10 5 ; provided by Douglas Golenbock, University of Massachusetts Medical School) were adhered to glass coverslips in 24 well tissue culture plates overnight at 37°C and 5% CO 2 . Washed monolayers were incubated with either M.tb strain Erdman or HN885 in either RH containing 2.5% human serum or RHH at 37°C for 2 h. Infected monolayers were washed, fixed, stained and bacteria/cell was assessed as described above.
Transmission electron microscopy (TEM) of strains Erdman and HN885 in macrophages
) were added to MDM monolayers on glass coverslips and incubated for 2 h at 37°C. Without washing, monolayers were fixed with 2.5% gluteraldehyde in 0.1 M Na-cacodylate buffer (pH 7.2) for 10 min followed by 1 h in fresh fixative. Coverslips staining and TEM analysis of attachment and internalization of strains HN885 and Erdman by the macrophage was performed as previously described (19) (20) . Pure ManLAM fractions were analyzed by electrophoresis using 10-20% gradient Tris/Tricine gels followed by periodic acid-silver (PAS) staining. Sample concentrations were 0.5 µg/µl sample buffer. Western blotting using anti-LAM CS-35 and CS-40 mAbs (21;22) was performed essentially as described (23) using a chemiluminescence system (Amersham Biosciences, Piscataway, NJ). Deacylation of ManLAMs and sizing chromatography using a 1x120 cm Bio-Gel P-100 (BioRad) column were performed as previously described (24) . Fractions were dried and carbohydrate content determined following the Dubois method (25) .
Monosaccharide composition and high performance anion exchange chromatography (HPAEC) analyses -Samples were hydrolyzed with 2 M trifluoroacetic acid and converted to alditol acetates using scyllo-inositol as internal standard. Gas chromatography (GC) was performed as described (20) . For HPAEC analyses, mixtures of ManLAM/LM from each strain were digested with endorabinanase and analyzed as previously described (20) . (27) . Infected monolayers were washed and either repleted with RH containing 1% human autologous serum and further incubated for 24, 48 or 72 h or lysed (0 h time point) as described (27) . After the 0 time point, the supernatant (containing detached infected MDMs) and monolayers were lysed separately and then pooled. Lysed samples were diluted and then duplicates of three dilutions for each group were plated on 7H11 agar plates for 2-6 weeks (colony counts were identical within this interval). Colony forming units (CFU) and doubling times were determined.
Matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) MS analyses
Statistical analysis -Statistical analyses were performed using GraphPad Prism version 4.0 (www.graphpad.com).
Results
Association of M.tb clinical isolates with primary human macrophages. We generated single cell suspensions (18) and using the same MOI (10:1) we evaluated the macrophage association patterns of randomly selected strains from each of the three PGGs in the presence or absence (±) of fresh nonimmune autologous serum. Fig. 1A shows a representative experiment for the association of HN885 and HN1554 clinical isolates vs. the Erdman strain in the presence (solid bars) or absence (open bars) of serum. Our results showed that only strains HN885, HN1554, and to a lesser extent HN1538 were significantly reduced in macrophage association ± serum relative to the control strain Erdman (Fig. 1B) . Regardless of the PGG, all clinical isolates analyzed had a greater association (2-3 fold) with human MDMs in the presence of serum relative to the no serum condition (Fig. 1B) as previously shown for M.tb strains Erdman, H 37 R v and H 37 R a (19) . To further analyze the result for the HN885 and HN1554 strains, we determined that the reduced association was observed regardless of the age of the bacterial culture used (standard 9 days vs. 3 weeks) and the multiplicity of infection. Also, we determined that there was no difference in the degree of bacterial clumping or the stability of the bacterial phenotype (several serial passages on plates) (data not shown). Under all conditions, the reduction in bacterial association was greatest for strain HN885.
Receptor-mediated phagocytosis for strains Erdman, HN885 and HN1554. A highly expressed pattern recognition receptor on alveolar macrophages is the MR (28) . We previously showed that the MR directly participates in the phagocytosis of virulent M.tb strains defining a unique pathway for their intracellular trafficking (2;19 ). Thus, we tested if the low association with human macrophages observed for HN885 and HN1554 was due to a deficiency in the recognition by the MR by using an anti-MR mAb (2;3). Results in Fig. 2A show a representative experiment in the absence (open bars) or presence (solid bars) of anti-MR mAb and in Fig. 2B show combined data from three independent experiments. Whereas the association of strains Erdman and H 37 R v with macrophages was significantly reduced when MDM were pretreated with MR mAb (40.3 ± 8.4% and 47.8 ± 7.2%, respectively), the association of strains HN885 and HN1554 was minimally reduced in the presence of MR mAb (13.3 ± 8.2% and 5.1 ± 3.7%, respectively). Taken together, these data provide evidence that whereas strains Erdman and H 37 R v engage the macrophage MR to optimize association with the macrophage (19) , strains HN885 and HN1554 do not. The results suggested that these clinical isolates have an alteration(s) in their mannosylated cell wall molecules (i.e. reduction of ManLAM and higher-order PIMs, both known MR ligands) that impaired their recognition by the MR.
CR3 is also a major receptor involved in M.tb phagocytosis by human macrophages in both the absence and presence (via C3 deposition) of serum (18) . Our results show that there is no difference in the magnitude or nature of C3 fragment deposition on strains Erdman and HN885 or in the association with CR3 (supplemental Fig. 1 ).
We next studied whether the low association with macrophages observed for HN885 also translated into a defect in macrophage internalization (phagocytosis) of bacilli. Using TEM (19), we found that only under non-opsonic conditions (data for the opsonic condition is not shown) there was a significant difference (*P<0.05, n = 3) between Erdman and HN885 strains in that 89.6 ± 0.6% of strain Erdman were internalized after 2 h of infection, whereas only 58.0 ± 10.6% of strain HN885 were internalized (Fig. 2C ). This result indicated that the defect in association observed for HN885 was also accompanied by a defect in phagocytosis under non-opsonic conditions, where the difference between strains HN885 and Erdman is in use of the MR by the latter strain.
Analysis of ManLAM on the surface of strains HN885 and HN1554. As ManLAM is the major M.tb cell envelope ligand for the MR, we next assessed whether strains HN885 and HN1554 are deficient in cell surface exposure of ManLAM. ELISA and flow cytometry experiments were performed using anti-LAM mAbs (CS-35 and CS-40) (21;22). The whole cell ELISA results using CS-35 and CS-40 ( Fig. 2D) showed a significant reduction in the recognition of surface ManLAM on strains HN885 and HN1554 (P<0.0001), a result confirmed by flow cytometry (supplemental Fig. 2 ). Analysis of cell lysates by SDS-PAGE and Western blot based on loading protein equivalents demonstrated that the ManLAM content was equivalent among all strains (data not shown). Thus, the reduced exposure of ManLAM observed on the surface of HN885 and HN554 appeared to be due to an alteration in their ManLAM structure and/or location.
Size and molecular composition of ManLAMs from strains HN885 and HN1554. To examine for structural alterations present in ManLAMs from strains HN885 and HN1554, these were extracted and purified by size-exclusion chromatrography as we previously described (20) . By Tris/Tricine-PAGE, HN885 and HN1554 exhibited a greater electrophoretic mobility indicative of a smaller size (Fig. 3A) . Western blot analysis confirmed this result and also showed all ManLAMs to react similarly to mAbs CS-35 and CS-40 (which recognize the terminal branched Ara 6 motif and the mannose-capped terminal arabinosyl epitopes of ManLAM, respectively; data not shown). To provide a different analytical perspective, Erdman, HN885 and HN1554 ManLAMs were deacylated by mild alkali treatment (dManLAM), and the size of their carbohydrate cores was determined on a P-100 sizing column. The three preparations generated different profiles (Fig. 3B) . Erdman ManLAM eluted in earlier fractions (#32-#41) than the ManLAMs from HN885 (#38-#47) and HN1554 strains (#39-#48, data not shown) indicating that the carbohydrate cores of HN885 and HN1554 ManLAMs were smaller. The size variation observed for HN885 and HN1554 ManLAMs was further estimated by matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS). The negative MALDI-TOF-MS spectrum of Erdman ManLAM showed a broad unresolved peak centered at m/z 18,500 (Fig. 3C) , indicating a molecular mass of approximately 18.5 kDa, the major molecular species observed for this lipoglycan (29) . Analysis of ManLAMs from HN885 and HN1554 (Fig. 3C) revealed a smaller average molecular mass of approximately 16.5 kDa and 15.0 kDa, respectively (Fig. 3C) . ManLAM monosacharide composition analysis by GC showed an arabinose (Araf) to mannose (Manp) ratio of 1.18 and 1.02 to 1 for strains HN885 and HN1554, respectively, which is comparable to those of strain Erdman and H 37 R v ManLAMs (Table 1) . However, when neutral sugar composition was quantified based on one inositol/mol of ManLAM, strain HN885 ManLAM yielded 32 Araf and 27 Manp residues compared to 56 Araf and 49 Manp residues for ManLAM from strain Erdman. Similar differences (less Araf and Manp residues) were observed for the ManLAM from strain HN1554 also consistent with its smaller size (Table 1) . Thus, the absolute neutral sugar composition is in support of an overall smaller size for HN885 and HN1554 ManLAMs, consistent with their greater migration by Tris/Tricine-PAGE, their P-100 column elution profiles and their MALDI-TOF MS spectra.
Erdman, HN885 and HN1554 ManLAM fatty acid composition was also determined by GC/MS after methanolysis and trimethylsilylation (20) . The ions at m/z 270 and 312, which correspond to hexadecanoic acid (C 16:0 ) and ∆10-methyloctadecanoic acid (C19 or tuberculostearic acid), respectively, were found in all ManLAMs. In addition both HN885 and HN1554 contained an octadecanoic acid (C 18:0 , m/z 298) (data not shown).
Enzymatic digestion and Methylation analysis of ManLAMs. Enzymatic digestion of arabinan by
Cellulomonas endoarabinanase has been used as a means to analyze specifically the nature of the non-reducing termini of ManLAM (30) . Erdman, HN885 and HN1554 ManLAMs were digested with endoarabinanase and the products were analyzed by Dionex-HPAEC. The HPAEC profile of the digested ManLAM of strain Erdman revealed three major characteristic oligosaccharide peaks [Ara 2 (representative of the internal regions of the arabinan) and Man 2 Ara 4 and Man 4 Ara 6 (both representative of the linear and branched non-reducing termini of ManLAM-arabinan, respectively)] and a much smaller peak for the non-mannose capped Ara 6 (Fig. 4A) . However, HN885 and HN1554 digested ManLAM HPAEC profiles (Fig. 4A) showed a significant reduction in the relative abundance of the ManLAM-derived Ara 2 fragments (a decrease of 33.0% and 49.3% for HN885 and HN1554, respectively), indicating a size reduction in their arabinans. An overall reduction in the amounts of Man 2 Ara 4 , Man 4 Ara 6 6 and Ara 6 fragments (esp. Man 4 Ara 6 ) was also observed when compared to those of strain Erdman (Fig. 4B) . Subsequent treatment of the endoarabinanase-treated material with α-mannosidase confirmed the identity of the mannose-capped Ara 4 and Ara 6 fragments (data not shown).
Linkage analysis was also performed to further examine differences in the arabinan and mannan structures within the ManLAMs of these strains. The permethylated alditol acetate profiles of Erdman, HN885 and HN1554 ManLAMs were established by GC/MS (Fig. 5A ). The bar graph in Fig. 5B reflects the linkage compositional analysis of all ManLAMs based on areas under the curve for each sugar type detected by GC/MS. Three major conclusions were derived from this experiment. First, the content of 5-Ara (5-α-Ara + 5-βAra) is lower in both clinical isolate ManLAMs. This result corresponds directly with the decrease in Ara 2 observed for the Dionex-HPAEC profiles, where Ara 2 is exclusively defined as Araf-α[1→5]Araf disaccharide. The fact that the decrease in 5-Ara by methylation analysis is not as marked as the decrease observed for Ara 2 by HPAEC analysis can be explained by the fact that both clinical isolate ManLAMs are more branched in their arabinan domain (i.e. contain more 3,5-Ara) (Fig. 5B) . Previous structural analysis (31;32) showed that for each 3,5-Ara there are two 5-β-Ara residues (for mannose capped branches only). Because we can not differentiate among α-and β-isomers by linkage analysis; the slight increase of 5-β-Ara in the clinical isolate ManLAMs masks the decrease of 5-α-Ara observed by our HPAEC experiments. The presence of more 5-β-Ara in both clinical isolate ManLAMs could also be explained by both ManLAMs having greater values for the residues related to their mannose-caps (i.e. t-Man and 2-Man). Methylation analysis does not allow us to exclude this possibility as t-Man and 2-Man can also be related to the mannan domain of ManLAM. Second, the content of 6-Man was markedly reduced in both clinical isolates, where 6-Man defines the linear mannan core of ManLAM.
The third and most interesting conclusion is that all of the differentially linked Araf and Manp residues were present in all of the ManLAMs analyzed, and their relative ratios did not change significantly, indicating that both HN885 and HN1554 ManLAMs have a reduction in their arabinan and mannan content, while retaining their basic structure as observed for Erdman.
Structural features of
1 H-
13
C heteronuclear single quantum coherence (HSQC) NMR (Fig. 6A) . The assignment of the resonances in a 1D 1 H-NMR can be challenging as the protons are in a strong overlapping region of the spectrum. However, as previously reported (33) , this approach allowed us to identify two intense broad triplets centered between δ2.5 and δ2.65 ppm, which were attributed to the methylene of the succinyl groups located in the C-2 of the branched 3,5-Araf in the ManLAM arabinan (33) (data not shown). Upon deacylation, the resonances for succinates and fatty acids (δ2.65-0.5) were removed indicating their covalent ester bonds (20) .
Resonances related to the overlapping anomeric region can be better resolved by 2D- C HSQC NMR spectra from the HN885, HN1554 and Erdman ManLAMs, and in agreement with our previous work (20) , the spin systems of all mannose types could be determined (Table 2) . Spectral data on different ManLAMs were acquired on separate days and the chemical shift changed by 0.1-0.3 ppm. Chemical shifts for Erdman ManLAM were taken as a generic standard for analysis of the HN885 and HN1554 ManLAMs. Both clinical isolate ManLAMs demonstrated an overall reduction in their spin systems related to their mannan domain. However, when the 2,6-α-Manp/(2,6-α-Manp + 6-α-Manp) ratio (29) was calculated from the H-1 signal integration values, a degree of branching of 70%, 80% and 87% for Erdman, HN885 and HN1554, respectively, was obtained. These data are in agreement with the difference in the degree of branching determined by our methylation analysis (i.e. 11% and 21% increase in branching in the HN885 and HN1554 mannan cores, respectively, when compared to Erdman). A marked difference between both clinical isolates and Erdman was also observed for the spin system corresponding to 6-α-Manp (δ102.2, δ5.00); where HN885 and HN1554 showed a 2.6-fold and a 1.4-fold decrease, respectively, when compared to Erdman ManLAM. Thus, in comparison to Erdman ManLAM, both clinical isolates had a shorter mannan core with a higher degree of branching. Although overlapping anomeric signals for t-α-Manp (δC 1 102.2, δH 1 5.00) were assigned to both the mannan core and mannose caps, and these were less prominent in both clinical isolates, the t-α-Manp/(t-α-Manp + 2-Manp) ratio indicated no marked differences in their degree of mannosecapping or the lengths of mannose caps (i.e. mono-,di-, or trimannosides) when compared to Erdman ManLAM (i.e. ~60% for Erdman and HN885 and 68% for HN1554). This result is also in agreement with our methylation analysis where a slight increase in the degree of mannose capping was only observed for HN1554 ManLAM.
As observed previously for mycobacterial LAMs, some Ara units with identical spin systems had multiple H-1 signals that led to the assignment of one 3,5-α-Araf volume, four 5-α-Araf volumes, two 2-α-Araf volumes and a single t-β-Araf + 5-β-Araf volume for Erdman ManLAM, representing the different positions that each Ara unit may have within the arabinan domain (Fig.6C) . Consistent with our previous results (20) , the HSQC spectrum for Erdman ManLAM presented a series of spin signals attributed to 5-α-Araf and 3,5-α-Araf . In both HN885 and HN1554 ManLAMs, these signals (especially the spin volume for 5-α-Araf, Two spin systems were also identified for 2-α-Araf, those attached to the 3-position (2-α-Araf→3, δ105.4, δ5.21) and 5-position (2-α-Araf→5, δ105.6, δ5.14) of the 3,5-α-Araf (δ107.4, δ5.11). As expected, the intensity of 2-α-Araf→5 signal was stronger than that of 2-α-Araf→3 due to the lack of substitution in the C-3-position, which results in the terminal linear Ara 4 motif. Although both volumes were smaller in the clinical isolate ManLAMs, the ratios 2-α-Araf→5/(3,5-Araf + 2-α-Araf→5) and 2-α-Araf→3/(3,5-Araf + 2-α-Araf→3) indicated a slight increase in their branching patterns when compared to Erdman arabinan.
The chemical shifts at C 1 δ100.6 and H 1 δ5.10 corresponded to the terminal β-Araf with overlapping 5-β-Araf and their volumes were also smaller in both clinical isolates when compared to Erdman ManLAM. In the NMR spectra the anomeric signals for t-β-Araf and 5-β-Araf had a perfect overlap, however, the substitution on the 5-OH by the mannose caps results in a significant shift at the C-5 of the β-Araf (20). From the same 1 H- 13 C HSQC NMR spectra, detailed analysis of the hydroxymethylene region showed that all ManLAMs had 5-β-Araf with a similar ratio for C-5 of 5-β-Araf/t-β-Araf indicating a similar amount of t-β-Araf in all ManLAMs (data not shown). Similar results were obtained by methylation analysis with a t-Ara ratio of 0.92:1.00:1.13 for Erdman, HN885 and HN1554 ManLAMs, respectively. The recently defined signal corresponding to 5-deoxy-5-methylthioxylofuranose (MTX) residue was observed in Erdman and H 37 R v ManLAMs only. However, its corresponding oxidized counterpart, 5-deoxy-5-methylsulfoxy-xylofuranose (MSX) was observed in all of the ManLAMs studied (35) . Thus, the data derived from the 1 H-13 C HSQC NMR spectra, together with the methylation and HPAEC analyses, provide evidence that the ManLAMs from clinical isolates HN885 and HN1554 have a decrease in their ManLAM length with a notable truncation of their linear arabinan (i.e. decrease of 5-α-Araf) and mannan (i.e. decrease of 6-α-Manp) domains, with the latter highly substituted by t-Manp and/or several shorter arabinan chains. However, we can rule out the possibility of multiple shorter arabinan chains, as our results do not support these structures in all M.tb ManLAMs studied (i.e. high values for 2-α-Araf and 3,5-α-Araf relative to the decrease of 5-α-Araf observed)
Total PIM content in the cell envelope of strains Erdman, HN885 and HN1554. In addition to ManLAM, we recently showed that higher-order PIMs on the cell surface of virulent M.tb strains also associate with the MR during phagocytossis and contribute to the mycobacterial phagosome maturation arrest (3). Thus, we analyzed the total PIM composition on the cell envelope of HN885 and HN1554 to determine if their reduction might be another reason for low association with the MR. Total PIMs were extracted and analyzed by MALDI-TOF MS (Fig. 7) and 2D-TLC (supplemental Fig. 3) . Results show that all strains contained all of the predicted PIMs and there were no differences in their acylation patterns. Figure  7A shows the total PIM MALDI-TOF MS spectra for Erdman, HN885 and HN1554 strains. Three major signals were determined, m/z 891.7 can be assigned as [M+K] + for phosphatidyl-myo-inositol with palmitic (C 16:0 ) and tuberculostearic (TBST) acids on the C-1 and C-2 position of the glycerol. The signal m/z 1476.0 can be assigned as [M+Na-H+K] + for Ac 1 PIM 2 (a lower-order PIM) with an additional C 16:0 either on the C-6 position of the α(1→2) linked mannose or on the C-3 of the myoinositol (36) . The signal at m/z 2124.5 corresponding to [M+Na-H+K] + of Ac 1 PIM 6 , a higher-order PIM which engages the MR and contributes to the limited phagosome-lysosome fusion (3), was also observed. Our results by MS (Fig. 7B ) and corroborated by densitometry on the 2D-TLC (Fig. 3 supplement) indicate that HN885 and HN1554 clinical isolates have a decrease in terminal α2-Manp of their PIMs when compared to strain Erdman.
In addition to PIMs, strains HN885 and HN1554 also contained abundant pthiocerol dimycocerosates (PDIM), triglycerides (supplemental Fig. 4A ) and phenolic glycolipid (PGL) (supplemental Fig. 4B and C) in their cell envelope, all known M.tb virulence factors (14-16). These were not observed in the laboratory strain Erdman. Thus, we speculate that the presence of PDIM, triglycerides and PGL in these clinical isolates, in addition to their truncated form of ManLAM and their general decrease in higherorder PIMs, may serve to further mask the already low content of surface exposed terminal α(1→2)-Man explaining the poor recognition of these clinical isolates by the human macrophage MR.
Intracellular growth of strains Erdman and HN885.
There is increasing evidence that the use of a specific receptor(s) on the surface of the human macrophage by M.tb can dictate the outcome of M.tb infection (37) . Here we show that HN885 and Erdman differ in their use of the MR during phagocytosis. Therefore, to determine whether this difference would lead to differences in their intracellular growth in macrophages, MDMs were incubated with each strain, CFU assays were performed and doubling times in macrophages calculated. Results show that for non-opsonized bacilli (no serum), the doubling time for strain HN885 was the same as Erdman (Table 3 ). In contrast, following serum opsonization, the doubling time for strain HN885 was reduced when compared to Erdman (Table 3) . Thus, although reduced in phagocytosis, and therefore less internalized for a given MOI ( Fig.  2A-C) , those strain HN885 bacilli that do enter macrophages divide more rapidly than the M.tb Erdman strain, a finding that is most evident after serum opsonization.
Discussion
Continued efforts to define the molecular events in the early interaction between M.tb and the human macrophage are necessary to further understand the immunopathogenesis of TB and disease outcome. This study has identified two M.tb strains (i.e. HN885 and HN1554) among a bank of M.tb clinical isolates (8;17) with a striking defect in phagocytosis by primary human macrophages when compared to strain Erdman, a commonly used laboratory strain for studies of pathogenesis. The defect in phagocytosis was found to result from significant alterations in the mannosylated cell envelope components of these strains that impact recognition by the macrophage MR and intracellular bacterial survival.
ManLAM is a predominant lipoglycan of the M.tb cell envelope that has been found to play a central role in the virulence and immunopathogenesis of TB (38) . ManLAM and higher-order PIMs (i.e., PIM 5 and PIM 6 ), mediate phagocytosis of bacilli by human macrophages via the MR resulting in limited phagosome-lysosome fusion events for this bacterium (2;3). The cell biological effects of ManLAM are numerous and the focus of research in a number of laboratories [Reviewed in (37) ]. In many cases, these biological effects are linked to the nature and extent of the mannose capping as well as to other substitutions in the arabinan chains. To date, ManLAM structures have been determined from only a limited number of M.tb strains. Here we provide the first report of two clinical isolates of M.tb that do not expose ManLAM on their surface. This is not due to a difference in their total ManLAM content when compared to the Erdman and H 37 R v strains, but rather to a difference in the structure and location of the ManLAMs from these isolates.
When purified ManLAMs were subjected to rigorous biochemical analysis, our results demonstrated that strains HN885 and HN1554 contain an overall shorter and in several respects simpler ManLAM (Fig. 8A) . Specifically, our sugar analysis, HPAEC, methylation and NMR analyses showed that ManLAM molecules from HN885 and HN1554 have a marked reduction in Araf residues, which correspond mainly to the inner Araf-α[1→5]-Araf (known as Ara 2 ) unit of the arabinan domain. Our results also indicate that both HN885 and HN155 arabinans are composed of a limited number of short arabinose chains (i.e. 1 to 2 chains per ManLAM molecule). In addition, the mannan domain of their respective ManLAMs is altered with less 6-Manp residues indicating a shorter but more substituted linear Manp-α[1→6]-Manp unit (Fig. 8A) . The structurally truncated ManLAM molecule produced by HN885 and HN1554 likely reduces its surface availability.
To date, truncated ManLAMs have only been observed in M.tb ethambutol resistant strains under laboratory conditions (20;39); in contrast, the M.tb strains reported here are all ethambutol susceptible (data not shown). We also found that there was a marked reduction of higher-order PIMs. Less exposed ManLAM and reduced higher-order PIMs translated to a low association of these clinical isolates with the MR and reduced phagocytosis by human macrophages as seen in our TEM studies.
It is also possible that the ManLAMs from strains HN885 and HN1554 have a less favorable spatial conformation for engaging the MR; however we reason that their ManLAMs have the same spatial flexibility in their carbohydrate domains as indicated by their Araf:Manp ratio values, which are similar to the Erdman and H 37 R v strains (Table  1 ). In addition, we found that strains HN885 and HN1554 have abundant dimycocerosates, triglycerides, and to a lesser extent PGL, in their cell envelopes. We speculate that the presence of these molecules further masks the exposure of ManLAM and the higher-order PIMs. Overall, our data indicate that low binding to the MR is a direct consequence of a significant reduction in α[1→2] mannosylated surface-exposed components in the cell envelope of these clinical isolates.
Strains HN885 and HN1554 displayed normal C3 opsonization and interaction with host cell CR3 (supplemental Fig. 1 ). However, these results do not exclude the possibility that the binding to other CRs [e.g. CR1 and CR4 (40)] may be altered. Our results are consistent with the idea that CRs cooperate with the MR for optimal phagocytosis by macrophages. Akin to other models of lectin/integrin interactions, the MR may be particularly important in enhancing the initial adhesion of bacteria to macrophages prior to efficient internalization mediated by itself and/or the CRs. Finally, although the MR and CRs are the main phagocytic receptors described for M.tb on primary human macrophages, other receptors for M.tb phagocytosis have been described [reviewed in (37) ], which may be altered in their interaction with these clinical isolates and were not the focus of the current study.
Our data show that despite the decrease in macrophage phagocytosis of HN885 (Fig. 2C ) and consequently number of intracellular bacteria, the intracellular growth rate (expressed as doubling time, Table 3 ) for those HN885 bacilli that do enter macrophages is similar to Erdman in the absence of serum, and faster (shorter doubling time) than Erdman in the presence of serum. This suggests that the mechanisms for intracellular survival and growth of HN885 (and potentially for other clinical isolates) following phagocytosis are fundamentally different from the ones described for Erdman and H 37 R v [reviewed in (37) ] and worthy of further study.
Our results lead us to propose a new model for the phagocytosis of M.tb strains by human macrophages (Fig. 8B) . M.tb strains that have less surface mannosylation do not use the MR during phagocytosis. Such strains are reduced in phagocytosis, relying primarily on C3 opsonization and the CR pathway for entry (a more primitive entry pathway). However, these strains demonstrate rapid in vitro intracellular growth. Conversely, M.tb strains that are heavily surface mannosylated have become more hostadapted in part by increasing surface mannosylation with mannans that resemble the glycoforms of eukaryotic mannoproteins that are normally recycled by the homeostatic MR (4). In support of this concept, M.tb was recently found to contain a mammalian mannosyltransferase homologue, (41); thus, establishing that the process of mannosylation is conserved at least to some extent between M.tb and eukaryotic organisms. This concept of M.tb pathways mimicking aspects of human biosynthetic pathways is further supported by recent studies revealing other typical eukaryotic aminosugar substitutions on components of the M.tb cell envelope (42;43).
Thus, more host-adapted M.tb strains expose a large and heavily mannosylated ManLAM and greater amounts of higher-order PIMs that bind to the MR. Such strains are optimized in phagocytosis by cooperatively engaging the MR and CRs. Use of the mannolipoglycan/MR pathway provides a safe portal for M.tb within the macrophage by regulating the trafficking of bacteria and cytokine response. These strains grow more slowly in the macrophage and cause less tissue damage during infection. We speculate that such host-adapted strains would be highly successful in establishing an infection in humans but would more likely lead to the latent state rather than to an active disease state following infection. Further studies using banks of M.tb clinical isolates to define macrophage interactions are necessary to enhance our understanding of the molecular mechanisms of phagocytosis and M.tb intracellular adaptation to the human host. Table 2 . (B) Representation of the sugar linkages described for the mannan and (C) arabinan domains of ManLAM. , where "x" and "y" represent the number of branches and number of 6-α-Manp residues present in the mannan core, respectively. Erdman ManLAM has a longer (18 to 20 6-α-Manp residues) mannan domain when compared to HN885 and HN1554 (with 10-12 and 8-10 6-α-Manp residues, respectively). In addition, "z" represents the number of 5-α-Araf residues that forms the linear arabinan domain of ManLAM. Based on our results, this value was estimated to be about 42 to 44 for ErdManLAM whereas in the case of HN885 and HN1554 it is estimated to be 16-18 and 28-30, respectively, indicating that both clinical isolates have a shorter linear arabinan domain in their respective ManLAMs. (B) Proposed model for entry and subsequent consequences for HN885 and HN1554 strains in human macrophages. M.tb strains HN885 and HN1554 have reduced surface exposure of ManLAM and do not use the MR pathway during phagocytosis. These strains contain PDIM, triglycerides and PGL and demonstrate limited phagocytosis primarily via the C3-CR3 pathway and rapid intracellular growth. In contrast, M.tb Erdman and H 37 R v strains heavily coat their surface with mannose residues including a more complex ManLAM and increased amounts of higherorder PIMs, which promote phagocytosis by the MR pathway in concert with CRs. These highlymannosylated strains subvert the host immune response; however, they are more host-adapted, and infection is associated with less tissue damage and slower intracellular growth. a Signal volumes were normalized and integrated to a reference signal located at 13 C, 1 H (δ100.05, δ5.22) common to all of the ManLAMs studied. b MTX and MSX, 5-deoxy-5-methyl-5-sulfoxy-α-xylofuranose. c There is a significant overlap in 3,5-α-Araf with 5-α-Araf, and thus the integration of signal volumes of 3,5-α-Araf cannot be unambiguously assigned. This is one explanation for a lower value of this peak in this table. 
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